Identification of receptor domains that modify ligand binding to 5- hydroxytryptamine2 and 5-hydroxytryptamine1c serotonin receptors

MS Choudhary, S Craigo and BL Roth

Department of Psychiatry, Case Western Reserve University School of Medicine, Cleveland, Ohio 44106.

Serotonin [5-hydroxytryptamine (5-HT)] receptors are distinguished pharmacologically by their characteristic affinities for agonists and antagonists. Two serotonin receptors, the 5-HT2 and 5-HT1c, share a number of pharmacologic and structural properties while differing in their affinities for certain agonists and antagonists. To identify regions of the 5-HT2 and 5-HT1c receptors important for specifying their unique pharmacology, we constructed six chimeric 5-HT2/5-HT1c receptors in which domains of each receptor were exchanged. The abilities of several drugs to inhibit [3H]mesulergine bound to the chimeric and parent receptors transiently expressed in COS-7 cells were then examined. For spiperone and haloperidol (both butyrophenones), chimeras that exchanged transmembrane (TM) domains I and II or TMs I- III had the greatest effects on binding affinity. The binding affinity of cinanserin (a cinnamanilide) was significantly changed in all the chimeras studied. In contrast, the binding of ketanserin (a 4- fluorobenzoylpiperidine) was strongly influenced by chimeras that exchanged TMs I-III (but not I and II) and by chimeras that exchanged intracellular loop 3 to TM VII. 5-HT binding affinity was greatly altered for chimeras that exchanged domains of intracellular loop 3 to TM VII, with minor effects being noted for chimeras that exchanged TMs I and II and I-III. The affinities of the nonselective drugs mesulergine, mianserin, and m-chlorophenylpiperazine were relatively unaffected when domains of the 5-HT2 and 5-HT1c receptors were exchanged. Taken together, these results imply that structurally diverse 5-HT2 antagonists utilize distinct regions of the 5-HT2 receptor for high affinity binding.

Volume 42, Issue 4, pp. 627-633, 10/01/1992
Copyright © 1992 by American Society for Pharmacology and Experimental Therapeutics

This article has been cited by other articles:

				G. F. Elphick, W. Querbes, J. A. Jordan, G. V. Gee, S. Eash, K. Manley, A. Dugan, M. Stanifer, A. Bhatnagar, W. K. Kroeze, et al. The Human Polyomavirus, JCV, Uses Serotonin Receptors to Infect Cells Science, November 19, 2004; 306(5700): 1380 - 1383. [Abstract] [Full Text] [PDF]

				D. Yin, S. Gavi, H.-y. Wang, and C. C. Malbon Probing Receptor Structure/Function with Chimeric G-Protein-Coupled Receptors Mol. Pharmacol., June 1, 2004; 65(6): 1323 - 1332. [Abstract] [Full Text] [PDF]

				J. A. Gray, A. Bhatnagar, V. V. Gurevich, and B. L. Roth The Interaction of a Constitutively Active Arrestin with the Arrestin-Insensitive 5-HT2A Receptor Induces Agonist-Independent Internalization Mol. Pharmacol., May 1, 2003; 63(5): 961 - 972. [Abstract] [Full Text] [PDF]

				J. A. Gray, D. J. Sheffler, A. Bhatnagar, J. A. Woods, S. J. Hufeisen, J. L. Benovic, and B. L. Roth Cell-Type Specific Effects of Endocytosis Inhibitors on 5-Hydroxytryptamine2A Receptor Desensitization and Resensitization Reveal an Arrestin-, GRK2-, and GRK5-Independent Mode of Regulation in Human Embryonic Kidney 293 Cells Mol. Pharmacol., November 1, 2001; 60(5): 1020 - 1030. [Abstract] [Full Text]

				T. Wurch, F. C. Colpaert, and P. J. Pauwels Chimeric Receptor Analysis of the Ketanserin Binding Site in the Human 5-Hydroxytryptamine1D Receptor: Importance of the Second Extracellular Loop and Fifth Transmembrane Domain in Antagonist Binding Mol. Pharmacol., December 1, 1998; 54(6): 1088 - 1096. [Abstract] [Full Text]

				D. L. Willins and H. Y. Meltzer Direct Injection of 5-HT2A Receptor Agonists into the Medial Prefrontal Cortex Produces a Head-Twitch Response in Rats J. Pharmacol. Exp. Ther., August 1, 1997; 282(2): 699 - 706. [Abstract] [Full Text]

				B. L. Roth, M. Shoham, M. S. Choudhary, and N. Khan Identification of Conserved Aromatic Residues Essential for Agonist Binding and Second Messenger Production at 5-Hydroxytryptamine2A Receptors Mol. Pharmacol., August 1, 1997; 52(2): 259 - 266. [Abstract] [Full Text]

				N. Almaula, B. J. Ebersole, D. Zhang, H. Weinstein, and S. C. Sealfon Mapping the Binding Site Pocket of the Serotonin 5-Hydroxytryptamine2A Receptor. Ser3.36(159) PROVIDES A SECOND INTERACTION SITE FOR THE PROTONATED AMINE OF SEROTONIN BUT NOT OF LYSERGIC ACID DIETHYLAMIDE OR BUFOTENIN J. Biol. Chem., June 21, 1996; 271(25): 14672 - 14675. [Abstract] [Full Text] [PDF]